The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intracranial Atherosclerotic Disease Treatment Market Research Report 2025
Synopsis
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The global Intracranial Atherosclerotic Disease Treatment market was valued at US$ 841 million in 2023 and is anticipated to reach US$ 1474 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intracranial Atherosclerotic Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Atherosclerotic Disease Treatment.
Report Scope
The Intracranial Atherosclerotic Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intracranial Atherosclerotic Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intracranial Atherosclerotic Disease Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intracranial Atherosclerotic Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intracranial Atherosclerotic Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries.
The global Intracranial Atherosclerotic Disease Treatment market was valued at US$ 841 million in 2023 and is anticipated to reach US$ 1474 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Intracranial Atherosclerotic Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intracranial Atherosclerotic Disease Treatment.
Report Scope
The Intracranial Atherosclerotic Disease Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intracranial Atherosclerotic Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intracranial Atherosclerotic Disease Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Stryker
Balt
TERUMO
MicroPort
Acandis
Segment by Type
Stent
PTA Balloon
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intracranial Atherosclerotic Disease Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intracranial Atherosclerotic Disease Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intracranial Atherosclerotic Disease Treatment Market Overview
1.1 Product Overview and Scope of Intracranial Atherosclerotic Disease Treatment
1.2 Intracranial Atherosclerotic Disease Treatment Segment by Type
1.2.1 Global Intracranial Atherosclerotic Disease Treatment Market Value Comparison by Type (2024-2030)
1.2.2 Stent
1.2.3 PTA Balloon
1.3 Intracranial Atherosclerotic Disease Treatment Segment by Application
1.3.1 Global Intracranial Atherosclerotic Disease Treatment Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Intracranial Atherosclerotic Disease Treatment Market Size Estimates and Forecasts
1.4.1 Global Intracranial Atherosclerotic Disease Treatment Revenue 2019-2030
1.4.2 Global Intracranial Atherosclerotic Disease Treatment Sales 2019-2030
1.4.3 Global Intracranial Atherosclerotic Disease Treatment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intracranial Atherosclerotic Disease Treatment Market Competition by Manufacturers
2.1 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intracranial Atherosclerotic Disease Treatment Average Price by Manufacturers (2019-2024)
2.4 Global Intracranial Atherosclerotic Disease Treatment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intracranial Atherosclerotic Disease Treatment, Product Type & Application
2.7 Intracranial Atherosclerotic Disease Treatment Market Competitive Situation and Trends
2.7.1 Intracranial Atherosclerotic Disease Treatment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intracranial Atherosclerotic Disease Treatment Players Market Share by Revenue
2.7.3 Global Intracranial Atherosclerotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intracranial Atherosclerotic Disease Treatment Retrospective Market Scenario by Region
3.1 Global Intracranial Atherosclerotic Disease Treatment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intracranial Atherosclerotic Disease Treatment Global Intracranial Atherosclerotic Disease Treatment Sales by Region: 2019-2030
3.2.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Region: 2019-2024
3.2.2 Global Intracranial Atherosclerotic Disease Treatment Sales by Region: 2025-2030
3.3 Global Intracranial Atherosclerotic Disease Treatment Global Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2019-2030
3.3.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2019-2024
3.3.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Region: 2025-2030
3.4 North America Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.4.1 North America Intracranial Atherosclerotic Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
3.4.3 North America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.5.1 Europe Intracranial Atherosclerotic Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
3.5.3 Europe Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.6.1 Asia Pacific Intracranial Atherosclerotic Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
3.6.3 Asia Pacific Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.7.1 Latin America Intracranial Atherosclerotic Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
3.7.3 Latin America Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intracranial Atherosclerotic Disease Treatment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2030)
4.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2019-2024)
4.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales by Type (2025-2030)
4.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Type (2019-2030)
4.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2030)
4.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2019-2024)
4.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Type (2025-2030)
4.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Intracranial Atherosclerotic Disease Treatment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2030)
5.1.1 Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2019-2024)
5.1.2 Global Intracranial Atherosclerotic Disease Treatment Sales by Application (2025-2030)
5.1.3 Global Intracranial Atherosclerotic Disease Treatment Sales Market Share by Application (2019-2030)
5.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2030)
5.2.1 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2019-2024)
5.2.2 Global Intracranial Atherosclerotic Disease Treatment Revenue by Application (2025-2030)
5.2.3 Global Intracranial Atherosclerotic Disease Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Intracranial Atherosclerotic Disease Treatment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Stryker
6.1.1 Stryker Corporation Information
6.1.2 Stryker Description and Business Overview
6.1.3 Stryker Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Stryker Intracranial Atherosclerotic Disease Treatment Product Portfolio
6.1.5 Stryker Recent Developments/Updates
6.2 Balt
6.2.1 Balt Corporation Information
6.2.2 Balt Description and Business Overview
6.2.3 Balt Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Balt Intracranial Atherosclerotic Disease Treatment Product Portfolio
6.2.5 Balt Recent Developments/Updates
6.3 TERUMO
6.3.1 TERUMO Corporation Information
6.3.2 TERUMO Description and Business Overview
6.3.3 TERUMO Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 TERUMO Intracranial Atherosclerotic Disease Treatment Product Portfolio
6.3.5 TERUMO Recent Developments/Updates
6.4 MicroPort
6.4.1 MicroPort Corporation Information
6.4.2 MicroPort Description and Business Overview
6.4.3 MicroPort Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MicroPort Intracranial Atherosclerotic Disease Treatment Product Portfolio
6.4.5 MicroPort Recent Developments/Updates
6.5 Acandis
6.5.1 Acandis Corporation Information
6.5.2 Acandis Description and Business Overview
6.5.3 Acandis Intracranial Atherosclerotic Disease Treatment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Acandis Intracranial Atherosclerotic Disease Treatment Product Portfolio
6.5.5 Acandis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intracranial Atherosclerotic Disease Treatment Industry Chain Analysis
7.2 Intracranial Atherosclerotic Disease Treatment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intracranial Atherosclerotic Disease Treatment Production Mode & Process
7.4 Intracranial Atherosclerotic Disease Treatment Sales and Marketing
7.4.1 Intracranial Atherosclerotic Disease Treatment Sales Channels
7.4.2 Intracranial Atherosclerotic Disease Treatment Distributors
7.5 Intracranial Atherosclerotic Disease Treatment Customers
8 Intracranial Atherosclerotic Disease Treatment Market Dynamics
8.1 Intracranial Atherosclerotic Disease Treatment Industry Trends
8.2 Intracranial Atherosclerotic Disease Treatment Market Drivers
8.3 Intracranial Atherosclerotic Disease Treatment Market Challenges
8.4 Intracranial Atherosclerotic Disease Treatment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
